Recruiting

Imagined Acupuncture

Sponsor:

Massachusetts General Hospital

Code:

NCT07177820

Conditions

Chemotherapy-induced Peripheral Neuropathy

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Video-Guided Acupuncture Imagery Treatment (VGAIT)

Study Details

Brief summary:

Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)

Conditions

Chemotherapy-induced Peripheral Neuropathy

Study ID

NCT07177820

Start date

Jan 6, 2026

Status verified date

Jul, 2026

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • at least 18 years of age
  • have histologically confirmed stage I-III breast cancer,
  • have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
  • have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.

Exclusion Criteria:

  • concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
  • having metastatic or recurrent disease,
  • history of preexisting peripheral neuropathy prior to chemotherapy,
  • uncontrolled seizure disorder,
  • unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: VGAIT

Interventions

Video-Guided Acupuncture Imagery Treatment (VGAIT)

Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them

Primary outcome measure

  • Feasibility related outcomes [ Time Frame: 8 week ]

Central Contacts and Locations

Central contacts

Sierra Hodges

6177265004sahodges@mgb.org

Jian Kong

16179620978jkong2@mgh.harvard.edu

Locations

Massachusetts General Hospital

Recruiting

Charlestown, Massachusetts, United States, 02129

Contacts

Sierra Hodges, B.S.

617-726-5004sahodges@mgb.org

More Information

Sponsor

Massachusetts General Hospital

Last update posted

Jul 22, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-07-22.